Breast cancer-related mortality in Central and Eastern Europe: years of life lost and productivity costs.

[1]  P. Golusiński,et al.  Lost productivity due to head and neck cancer mortality in Hungary, Poland, and Romania. , 2022, Journal of cancer policy.

[2]  C. la Vecchia,et al.  Persisting cancer mortality gap between western and eastern Europe. , 2022, European journal of cancer.

[3]  N. Harbeck,et al.  Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer , 2022, Therapeutic advances in medical oncology.

[4]  A. Gavin,et al.  The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers , 2021, European journal of cancer.

[5]  C. Diorio,et al.  Breast Cancer Treatments: Updates and New Challenges , 2021, Journal of personalized medicine.

[6]  H. Wildiers,et al.  Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based study , 2021, ESMO open.

[7]  J. Mortimer,et al.  De-escalation of Systemic Therapy for Early-Stage, Node-Negative Her2+ and Triple-Negative Breast Cancer , 2021, Current Breast Cancer Reports.

[8]  C. la Vecchia,et al.  European trends in breast cancer mortality, 1980-2017 and predictions to 2025. , 2021, European journal of cancer.

[9]  M. Pepels,et al.  Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands , 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[11]  V. Balakrishnan,et al.  Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities , 2021, Medicina.

[12]  F. Sardanelli,et al.  Do we still need breast cancer screening in the era of targeted therapies and precision medicine? , 2020, Insights into Imaging.

[13]  J. Trogdon,et al.  Productivity costs associated with metastatic breast cancer in younger, midlife, and older women. , 2020, Cancer.

[14]  B. Jönsson,et al.  The cost of cancer in Europe 2018. , 2020, European journal of cancer.

[15]  J. Thornton.  Targeted breast screening could reduce overdiagnosis and be more cost effective, study finds , 2018, British medical journal.

[16]  Harmonised unemployment rate , 2018, Main Economic Indicators.

[17]  K. To,et al.  Recent Advances in the Treatment of Breast Cancer , 2018, Front. Oncol..

[18]  E. Nojszewska,et al.  Productivity losses and public finance burden attributable to breast cancer in Poland, 2010–2014 , 2017, BMC Cancer.

[19]  M. Akram,et al.  Awareness and current knowledge of breast cancer , 2017, Biological Research.

[20]  F. Gany,et al.  Women With Breast Cancer Who Work For Accommodating Employers More Likely To Retain Jobs After Treatment. , 2017, Health affairs.

[21]  S. S. Guraya,et al.  Breast cancer screening programs: Review of merits, demerits, and recent recommendations practiced across the world , 2016, Journal of microscopy and ultrastructure.

[22]  T. Rosol,et al.  Triple-negative breast cancer: is there a treatment on the horizon? , 2016, Oncotarget.

[23]  C. la Vecchia,et al.  Cancer Control in Central and Eastern Europe , 2016, The oncologist.

[24]  C. Bradley.  Economic recovery: A measure of the quality of cancer treatment and survivorship? , 2015, Cancer.

[25]  Z. Vokó,et al.  Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary. , 2015, Value in health regional issues.

[26]  I. Soerjomataram,et al.  Measuring the societal burden of cancer: The cost of lost productivity due to premature cancer‐related mortality in Europe , 2015, International journal of cancer.

[27]  L. Schwartzberg,et al.  Indirect costs associated with metastatic breast cancer , 2013, Journal of medical economics.

[28]  G. Bodoky,et al.  Cancer epidemiology in Central and South Eastern European countries , 2011, Croatian medical journal.

[29]  Heather L. Bednarek,et al.  Employment-Contingent Health Insurance, Illness and Labor Supply of Women: Evidence from Married Women with Breast Cancer , 2005, Health economics.

[30]  R. Blanks,et al.  Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality , 2000, BMJ : British Medical Journal.